Log in to save to my catalogue

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, doubl...

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, doubl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1822256881

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare cause of demyelinating neuropathy, with multi-organ involvement characterised by plasma cell dyscrasia and VEGF overproduction. No treatments have been established for patients with POEMS syndrome who are not eligible for stem-cel...

Alternative Titles

Full title

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1822256881

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1822256881

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(16)30157-0

How to access this item